Halloran Speaker Series | The Future of RBQM and Customized Key Risk Indicator Libraries: How Small Companies Can Take Big Steps to Reduce Risk and Trial Oversight
Identifying the key risks to be monitored in a clinical study is critical for a successful implementation of a Risk-Based Quality Management process (RBQM), and even more, to the overall success of the clinical trial. Identifying the right Key Risk Indicators (KRIs) is also of utmost importance because they are the risk indicators that enable...